Mickisch G - Search Results

Year	Number of Results
1985	1
1986	1
1990	7
1991	7
1992	4
1993	3
1994	5
1995	3
1996	2
1997	2
1998	2
1999	5
2000	2
2001	7
2002	5
2003	3
2004	5
2005	2
2007	1
2009	1
2010	2
2011	1
2012	1
2013	3
2014	4
2015	1
2016	1
2020	3
2021	1
2022	1
2024	0

1

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.

Hussain M, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Roubaud G, Özgüroğlu M, Kang J, Burgents J, Gresty C, Corcoran C, Adelman CA, de Bono J; PROfound Trial Investigators. Hussain M, et al. N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Free article. Clinical Trial.

2

Erratum zu: Immuntherapie und Tyrosinkinaseinhibitoren beim metastasierten Nierenzellkarzinom in der First-line-Therapie – Wann welche Strategie?

Mickisch G, Peters I, Grüllich C, Mudra T, Doehn C. Mickisch G, et al. Urologe A. 2021 Mar;60(3):381-382. doi: 10.1007/s00120-021-01478-9. Urologe A. 2021. PMID: 33656593 Free PMC article. German. No abstract available.

3

Muscle-invasive urothelial carcinoma of the bladder.

Malkowicz SB, van Poppel H, Mickisch G, Pansadoro V, Thüroff J, Soloway MS, Chang S, Benson M, Fukui I. Malkowicz SB, et al. Among authors: mickisch g. Urology. 2007 Jan;69(1 Suppl):3-16. doi: 10.1016/j.urology.2006.10.040. Urology. 2007. PMID: 17280906 Review.

4

Chemoresistance of renal cell carcinoma: 1986-1994.

Mickisch GH. Mickisch GH. World J Urol. 1994;12(4):214-23. doi: 10.1007/BF00185677. World J Urol. 1994. PMID: 7820144 Review.

5

Principles of nephrectomy for malignant disease.

Mickisch GH. Mickisch GH. BJU Int. 2002 Mar;89(5):488-95. doi: 10.1046/j.1464-410x.2002.02654.x. BJU Int. 2002. PMID: 11929471 Review.

6

In vivo models of P-glycoprotein-mediated multidrug resistance.

Gottesman MM, Mickisch GH, Pastan I. Gottesman MM, et al. Among authors: mickisch gh. Cancer Treat Res. 1994;73:107-28. doi: 10.1007/978-1-4615-2632-2_6. Cancer Treat Res. 1994. PMID: 7710902 Review. No abstract available.

7

Multimodality treatment of metastatic renal cell carcinoma.

Mickisch GH. Mickisch GH. Expert Rev Anticancer Ther. 2002 Dec;2(6):681-5. doi: 10.1586/14737140.2.6.681. Expert Rev Anticancer Ther. 2002. PMID: 12503214 Review.

8

[Metastatic castration-resistant prostate cancer: position paper for structured therapy monitoring].

Miller K, Albers P, Eichenauer R, Geiges G, Grimm MO, König F, Mickisch G, Pfister D, Schwentner C, Suttmann H, Zastrow S. Miller K, et al. Among authors: mickisch g. Urologe A. 2014 May;53(5):710-4. doi: 10.1007/s00120-014-3491-7. Urologe A. 2014. PMID: 24806804 Review. German.

9

The genetic make-up of renal cell tumors.

Noordzij MA, Mickisch GH. Noordzij MA, et al. Among authors: mickisch gh. Urol Res. 2004 Aug;32(4):251-4. doi: 10.1007/s00240-002-0279-9. Urol Res. 2004. PMID: 15497212

10

[Immunotherapy and tyrosine kinase inhibitors in first-line treatment of metastatic renal cell carcinoma-Which strategy when?].

Mickisch G, Peters I, Grüllich C, Mudra T, Doehn C. Mickisch G, et al. Urologe A. 2020 Dec;59(12):1504-1511. doi: 10.1007/s00120-020-01320-8. Urologe A. 2020. PMID: 33026489 Free PMC article. Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year